Invasion of lymphatic vessels into the eye after open globe injuries

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 3717-3725

  Wesse, Julia M ^a   Hofmann Rummelt, Carmen ^a   Kruse, Friedrich E ^a   Cursiefen, Claus ^a,b   Heindl, Ludwig M ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; EYE INJURY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INJURY; LYMPH VESSEL; MALE; OPEN GLOBE INJURY; PATHOLOGY; PERFORATION; PRIORITY JOURNAL; RUPTURE; VISUAL ACUITY; WOUND HEALING; ENUCLEATION; LYMPH VESSEL ENDOTHELIUM; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD;

LAMININ; MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, LYMPHATIC; EYE ENUCLEATION; EYE INJURIES, PENETRATING; FEMALE; HUMANS; INFANT; LAMININ; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; YOUNG ADULT;

EID: 84865841894     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9507     Document Type: Article

References (28)

1. Cursiefen C, Kruse FE, Naumann GOH. Cornea and limbus. In: Naumann GOH, Holbach L, Kruse FE, eds. Applied Pathology for Ophthalmic Microsurgeons. Berlin: Springer; 2008:97-130.
2. Heindl LM, Hofmann-Rummelt C, Adler W, et al. Tumorassociated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology. 2010;117: 649-658.
3. Heindl LM, Hofmann-Rummelt C, Adler W, et al. Tumorassociated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci. 2011;52:7074-7083.
4. Heindl LM, Hofmann-Rummelt C, Adler W, et al. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology. 2011; 118:2351-2360.
5. Streilein JW, Yamada J, Dana MR, Ksander BR. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc. 1999; 31:1472-1475.
6. Schroedl F, Brehmer A, Neuhuber WL, Kruse FE, May CA, Cursiefen C. The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci. 2008;49:5222-5229.
7. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74:179-185.
8. Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol. 2006;4:217-228.
9. Kopfstein L, Veikkola T, Djonov VG, et al. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol. 2007;170:1348-1361.
10. Kukk E, Lymboussaki A, Taira S, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. 1996;122: 3829-3837.
11. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci. 1995;92:3566-3570.
12. Cursiefen C, Schlötzer-Schrehardt U, Kächle M, et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci. 2002;43:2127-2135.
13. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol. 2000;156:1499-1504.
14. Mimura T, Amano S, Usui T, Kaji Y, Oshika T, Ishii Y. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp Eye Res. 2001;72:71-78.
15. Cursiefen C, Maruyama K, Jackson DG, Streilein JW, Kruse FE. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea. 2006;25:443-447.
16. Heindl LM, Hofmann TN, Knorr HL, et al. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci. 2009;50:1988-1995.
17. Heindl LM, Hofmann TN, Adler W, et al. Intraocular tumorassociated lymphangiogenesis: a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology. 2010;117:334-342.
18. Heindl LM, Hofmann TM, Schrödl F, Holbach LM, Kruse FE, Cursiefen C. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread? Arch Ophthalmol. 2010;128:1001-1008.
19. Dietrich T, Bock F, Yuen D, et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol. 2010;184:535-539.
20. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003;22:273-281.
21. Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2009;247:289-302.
22. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394.
23. Yücel YH, Johnston MG, Ly T, et al. Identification of lymphatics in the ciliary body of the human eye: a novel "uveolymphatic" outflow pathway. Exp Eye Res. 2009;89: 810-819.
24. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666-2673.
25. Al-Rawi MA, Watkins G, Mansel RE, Jiang WG. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int J Oncol. 2005;27:721-730.
26. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050.
27. Hellmund K, Frühauf A, Seiler T, Naumann GO. Sympathetic ophthalmia 50 years after penetrating injury. A case report. Klin Monbl Augenheilkd. 1998;213:182-185.
28. Bock F, Onderka J, Dietrich T, et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2007;48:2545-2552.